Text Size
33 studies found for:    " December 09, 2009":" January 08, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir
2 Recruiting Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Conditions: HIV Infection;   HIV Infections
Intervention: Genetic: SB-728-T
3 Recruiting High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
4 Completed Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With HIV-1 Infection
Conditions: H1N1 Influenza Virus;   Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Interventions: Biological: Focetria®;   Biological: Begrivac®
5 Recruiting Medications for Chronic HIV: Education and Collaboration
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Medication Adherence
Intervention: Behavioral: MedCHEC tablet computer and Adherence Care
6 Recruiting Isentress Re-examination Study (MK-0518-115 AM1)
Conditions: HIV Infection;   HIV Infections
Intervention:
7 Completed Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test
Condition: HIV Infections
Intervention: Device: In Vitro Diagnostic Device
8 Completed TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278
Condition: HIV Infections
Intervention: Drug: TMC278 (Rilpivirine) LA; Placebo
9 Completed The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Condition: HIV Infections
Intervention:
10 Completed Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study
Condition: HIV Infection
Interventions: Procedure: GI endoscopy and GALT biopsies;   Biological: A sample of venous blood will also be collected
11 Completed Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
Conditions: HIV Infections;   Proteinuria
Intervention: Drug: change from tenofovir to raltegravir
12 Terminated Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects
Condition: HIV Infections
Intervention:
13 Unknown † A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
Condition: HIV Infections
Intervention: Drug: Kaletra and Intelence Tablets
14 Recruiting The Impact of Omega Three Fatty Acids on Vascular Function in HIV
Conditions: High Triglyceride Level;   HIV Infection
Intervention: Drug: Lovaza
15 Recruiting Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir disoproxil fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: Truvada
16 Completed A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: PF-04776548
17 Active, not recruiting Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)
Condition: HIV-1 Infections
Interventions: Drug: raltegravir; maraviroc; darunavir; ritonavir; tenofovir/emtricitabine;   Drug: darunavir; ritonavir; emtricitabine/tenofovir
18 Suspended Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Conditions: Sexually Transmitted Infections;   HIV Infections
Intervention:
19 Completed A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 formulation 1;   Drug: GSK2248761 reference formulation;   Drug: GSK2248761 formulation 3;   Drug: GSK2248761 formulation 2 or 4
20 Completed Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients
Conditions: HIV Infections;   Influenza
Intervention: Biological: naso-pharyngeal swab
To Top

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
† Indicates status has not been verified in more than two years